A seven percent solution

According to the latest data from Truveta Research, “As of December 2025, GLP-1 RA prescriptions account for more than 7% of all prescriptions”; tirzepatide leads the pack. Side note: While overall GLP-1 prescription rates rose slightly from September through December 2025, new prescriptions declined a bit, possibly because of the holidays.

GLP-1s: Keep your patients informed If you’re looking for a patient-friendly way to explain...

The latest article from the Partnership for Personalized Prescriptions — which you should share...

Going to Informa Connect’s Compounding Pharmacy Compliance Year-End Update in December in Philly?...

A seven percent solution

Related posts

GLP-1s: Keep your patients informed

Your patients should know this

At Informa: How GLP-1s changed compounding